The purpose of this funding opportunity announcement (FOA) is to support highly innovative, exploratory, collaborative research projects in the NCATS’ Clinical and Translational Science Award (CTSA) program, with the goal of assessing utility and feasibility of proposed innovation(s). This FOA will enable collaborative teams of investigators, from at least two different CTSA Institutions, to explore novel, generalizable approaches to important translational science questions, and to assess the utility and feasibility of such approaches. Collaborations that bring together ideas, theories, methods and approaches from disparate scientific disciplines are particularly encouraged.
Applications must involve investigators from at least 2 active CTSA institutions. For the purpose of this FOA, a CTSA institution is defined as the prime recipient of an active CTSA (U54/UL1) award or an active partner institution identified in the competing application for the CTSA award. To apply for this FOA, the CTSA institutions identified must be affiliated with CTSA awards (U54/UL1) that are active as of the application due date. For a list of CTSA hubs please see CTSA Program Hubs. For more information, please see CTSA Program Collaborative Innovation Awards.
The purpose of this funding opportunity announcement (FOA) is to invite applications to stimulate innovative collaborative research in the NCATS’ Clinical and Translational Science Award (CTSA) consortium. This FOA aims to support applications for innovative collaborative investigations (involving three or more CTSA sites) into improvements of the methods of translational research, at any step in the translational spectrum (T1-T4). For a list of CTSA hubs please see CTSA Program Hubs. For more information, please see CTSA Program Collaborative Innovation Awards.